CD4 and Recurrent upper respiratory tract infections: To assess the effect of the use of angular cheilitis and recurrent upper respiratory tract infections on the sensitivity, specificity and false negative rate to predict CD4<350cells/mm3 among patients in Stage I and II, a variable “clinical factor present” was generated if any of the patients in Stage II disease had one or both clinical factors of angular cheilitis and recurrent upper respiratory tract infection present.